Jeong-Han Kang

Title: Jeong-Han Kang: Innovator in Medical Research

Introduction

Jeong-Han Kang is a prominent inventor based in Rochester, MN (US). He has made significant contributions to the field of medical research, particularly in the treatment of fibrosis. With a total of 3 patents, his work focuses on innovative methods and materials that address critical health issues.

Latest Patents

One of his latest patents is titled "Using fatty acid synthase inhibitors to treat fibrosis." This document relates to materials and methods for treating fibrosis, such as pulmonary fibrosis. It provides methods for using one or more fatty acid synthase (FASN) inhibitors to treat a mammal suffering from fibrosis and complications associated with it, such as hypoxia caused by pulmonary fibrosis. Another notable patent is "Polypeptide inhibitors of SMAD3 polypeptide activities." This document outlines polypeptide inhibitors designed to inhibit Smad3 polypeptide activities. It includes methods and materials for using polypeptides that incorporate both a cell-penetrating amino acid sequence and an amino acid segment of a SH3 domain of a SNX9 polypeptide. Additionally, it discusses methods for using RNA interference to treat diseases, including fibrotic diseases in mammals.

Career Highlights

Jeong-Han Kang is affiliated with the Mayo Foundation for Medical Education and Research, where he continues to advance his research and innovations. His work has garnered attention for its potential impact on treating serious health conditions.

Collaborations

Some of his notable coworkers include Edward B Leof and Mark C Wilkes, who contribute to the collaborative efforts in their research endeavors.

Conclusion

Jeong-Han Kang's innovative work in medical research, particularly in the treatment of fibrosis, showcases his dedication to improving health outcomes. His patents reflect a commitment to advancing scientific knowledge and developing effective therapies.